CytomX Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, CA, dedicated to revolutionizing cancer treatment. With their distinctive Probody therapeutics, they aim to unlock the full potential of more potent and less toxic anti-cancer medications, offering a new generation of life-changing treatment options to patients.
Driven by a mission to destroy cancer differently, CytomX is known for its broad, clinical-stage pipeline and bold innovation. They are actively researching and developing therapies that outsmart cancer by turning its own weapons against itself, with the ultimate goal of transforming cancer treatment and improving patients' lives.
Generated from the website